Results 21 to 30 of about 2,070,589 (168)

Dexamethasone intravitreal implant in the treatment of diabetic macular edema

Clinical Ophthalmology, 2015
Pravin U Dugel,1,2 Francesco Bandello,3 Anat Loewenstein4 1Retinal Consultants of Arizona, Phoenix, AZ, 2Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; 3Department of Ophthalmology ...
Dugel PU, Bandello F, Loewenstein A
doaj   +1 more source

The Effects of Slow-Release Dexamethasone in the Treatment of Diabetic Macular Edema [PDF]

Pharmaceutics
Objectives: to evaluate the efficacy of 0.7 mg dexamethasone intravitreal implant in the treatment of patients with diabetic macular edema through mean retinal sensitivity (MRS), best corrected visual acuity (BCVA), central retinal thickness (CRT) and ...
Enzo Maria Vingolo, Simona Mascolo, Lorenzo Casillo, Mattia Calabro   +3 more
doaj   +2 more sources

Intracameral dexamethasone reduces inflammation on the first postoperative day after cataract surgery in eyes with and without glaucoma [PDF]

Clinical Ophthalmology, 2009
Diane TW Chang, Michael C Herceg, Richard A Bilonick, Larissa Camejo, Joel S Schuman, Robert J NoeckerDepartment of Ophthalmology, University of Pittsburgh Medical Center, Eye Center, Pittsburgh, PA, USAPurpose: To evaluate whether dexamethasone
Diane TW Chang, Michael C Herceg, Richard A Bilonick, Larissa Camejo, et al.   +4 more
doaj   +2 more sources

Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study

Clinical Ophthalmology, 2015
Wai-Ching Lam,1 David A Albiani,2 Pradeepa Yoganathan,3 John Chanchiang Chen,4 Amin Kherani,5 David AL Maberley,6 Alejandro Oliver,7 Theodore Rabinovitch,3 Thomas G Sheidow,8 Eric Tourville,9 Leah A Wittenberg,10 Chris Sigouin,11 Darryl C Baptiste12 ...
Lam WC, Albiani DA, Yoganathan P, Chen JC, Kherani A, Maberley DAL, Oliver A, Rabinovitch T, Sheidow TG, Tourville E, Wittenberg LA, Sigouin C, Baptiste DC   +12 more
doaj   +1 more source

Bilateral Intravitreal Dexamethasone Implant for Retinitis Pigmentosa-Related Macular Edema

Case Reports in Ophthalmology, 2013
Purpose: To report the efficacy of intravitreal dexamethasone implant in a patient with retinitis pigmentosa and bilateral cystoid macular edema unresponsive to topical carbonic anhydrase inhibitors.
Ali Osman Saatci, Ozlem Barut Selver, Goktug Seymenoglu, Aylin Yaman   +3 more
doaj   +2 more sources

Long-term follow-up of anatomical and functional macular changes after a single intravitreal implant of dexamethasone 0.7 mg for radiation macular edema secondary to proton beam therapy for choroidal melanoma. [PDF]

Int Med Case Rep J, 2016
To describe the efficacy and safety of a single intravitreal implant of dexamethasone in a patient affected by radiation maculopathy due to proton beam radiotherapy for choroidal melanoma.Retrospective data of a 46-year-old woman treated with a single intravitreal injection of dexamethasone for radiation maculopathy due to proton beam radiotherapy were
Stringa F, Marzi F, Giannì L, Imparato M, Bianchi A, Bianchi PE.   +5 more
europepmc   +7 more sources

Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study

Clinical Ophthalmology, 2015
The purpose of this study was to evaluate the real-world use, efficacy, and safety of one or more dexamethasone intravitreal implant(s) 0.7 mg (DEX implant) in patients with macular edema (ME).This was a retrospective cohort study of patients with ME secondary to retinal disease treated at ten Canadian retina practices, including one uveitis center ...
Sheidow, Thomas G., Lam, Wai Ching, Albiani, David A., Yoganathan, Pradeepa, Chen, John Chanchiang, Kherani, Amin, Maberley, David A L, Oliver, Alejandro, Baptiste, Darryl C., Sigouin, Chris, Wittenberg, Leah A., Tourville, Eric, Rabinovitch, Theodore   +12 more
openaire   +7 more sources

Dexamethasone Treatment Reverses Cognitive Impairment but Increases Brain Oxidative Stress in Rats Submitted to Pneumococcal Meningitis [PDF]

, 2011
Pneumococcal meningitis is associated with a significant mortality rate and neurologic sequelae. The animals received either 10 μL of saline or aS. pneumoniaesuspension and were randomized into different groups: sham: placebo with dexamethasone 0.7 mg/kg/
Felipe Dal-Pizzol, Jaqueline S. Generoso, Clarissa M. Comim, Fabricia Petronilho, João Quevedo, Andreza L. Cipriano, Tatiana Barichello, Ana Lucia B. Santos, Cintia Silvestre   +8 more
core   +1 more source

Long-term efficacy of dexamethasone intravitreal implant in the treatment of Vogt-Koyanagi-Harada disease relapsing posterior uveitis

Indian Journal of Ophthalmology, 2022
Purpose: To investigate the efficacy and safety of dexamethasone intravitreal implant in the treatment of relapsing posterior uveitis in patients with chronic recurrent Vogt–Koyanagi–Harada (VKH) disease.
Tarek R Elhamaky
doaj   +1 more source

Endothelial, Immunothrombotic, and Inflammatory Biomarkers in the Risk of Mortality in Critically Ill COVID-19 Patients: The Role of Dexamethasone

Diagnostics, 2021
Endothelial dysfunction, coagulation and inflammation biomarkers are increasingly emerging as prognostic markers of poor outcomes and mortality in severe and critical COVID-19.
Chrysi Keskinidou, Alice G. Vassiliou, Alexandros Zacharis, Edison Jahaj, Parisis Gallos, Ioanna Dimopoulou, Stylianos E. Orfanos, Anastasia Kotanidou   +7 more
doaj   +1 more source